Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats
Beyond its local gastrointestinal benefits, research suggests that orally administered BPC-157 can achieve systemic distribution, supporting healing processes throughout the body including joints, muscles, and connective tissues through mechanisms involving growth factor modulation and angiogenesis promotion
This period saw an increase in preclinical studies, investigating BPC 157s effects in animal models of injury, inflammation, and disease
New therapeutical treatment is therefore important to develop
Standard protocols range from 0.25mg to 0.5mg daily via subcutaneous injection for 4 to 8 weeks
Therefore, if you show any symptoms of pernicious anemia, begin injecting immediately